Neurocrine Biosciences, Inc. (BVMF:N1BI34)
Brazil · Delayed Price · Currency is BRL 39.09
-1.03 (-2.57%)
Last updated: Nov 12, 2025, 11:30 AM GMT-3
Neurocrine Biosciences Market Cap
Neurocrine Biosciences has a market cap or net worth of 77.54 billion as of November 13, 2025. Its market cap has increased by 15.72% in one year.
Market Cap
77.54B
Enterprise Value
74.18B
Revenue
14.30B
Ranking
n/a
PE Ratio
33.99
Stock Price
39.09
Market Cap Chart
Since May 23, 1996, Neurocrine Biosciences's market cap has increased from 206.46M to 77.54B, an increase of 37,457.19%. That is a compound annual growth rate of 22.26%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Nov 12, 2025 | 77.54B | -9.29% |
| Dec 31, 2024 | 85.48B | 36.07% |
| Dec 29, 2023 | 62.82B | 3.48% |
| Dec 30, 2022 | 60.70B | 34.84% |
| Dec 31, 2021 | 45.02B | -3.20% |
| Dec 31, 2020 | 46.51B | 16.88% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Rede D'Or São Luiz | 101.14B |
| Raia Drogasil | 39.23B |
| Hypera | 16.31B |
| Fleury | 8.62B |
| Odontoprev | 6.72B |
| Empreendimentos Pague Menos | 3.02B |
| Diagnósticos da América | 2.56B |
| Blau Farmacêutica | 2.26B |